Issue link: http://viewer.e-digitaledition.com/i/531147
COV ER FE AT UR E IN 1 9 9 9 , T H E A M E R I C A N M i g r a i n e S t u d y I I ind icated t hat nea rly 28 million people in the United States suffered from migraine headaches (MH). Subsequent studies have indicated a steady increase in this number — to more than 37 million today, according to the National Headache Foundation (NHF). Because MH are often misdiagnosed as sinus- or tension-related headaches, less than half of all migraine sufferers, according to the NHF, receive a diagnosis of (and treatment for) migraine — and one-third of those who are diagnosed and receive standard treatment do not find relief. Bahman Guyuron, MD, FACS, is the former Kiehn-DesPrez Professor and Chair of the Department of Plastic Surgery at Case Western Reserve University School of Medicine (Case) where he is currently an Emeritus Professor. For more than 15 years, he has been conducting migraine headache research in conjunction with Case, garnering worldwide attention and several research grants including a $3 million grant from the Elisabeth Severance Prentiss Foundation. "Migraines can be incapacitating, some- times lasting up to 72 hours or longer," says Dr. Guyuron. "Standard therapies do not help 33 percent of patients diag- nosed with periodic or chronic migraine headaches. In addition, even the most efficacious medications do not entirely eliminate migraine headaches but only reduce their severity and frequency." Bahman Guyuron, MD, FACS, is an Emeritus Professor at Case Western Reserve University School of Medicine. For over 15 years, he has been conducting migraine headache research in conjunction with Case, garnering worldwide attention and several research grants including a $3 million grant from the Elisabeth Severance Prentiss Foundation. Bahman Guyuron, MD, FACS: Migraine Surgery, By Robert Janek PHOTO © JOE SMITHBERGER, SMITHBERGER PHOTOGRAPHY, NORTH CANTON, OHIO 6 | Cleveland/Akron/Canton MD NEWS ■ M D N E W S . CO M ■ J U LY/AU G U S T 2 0 1 5